🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs

Recruitingn/aAges 18 Years - anyFemaleUniversité Catholique de Louvain
NCT06373822 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Objectives: To identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods Hypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease Study Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Pre-menopausal Exclusion Criteria: * HIV or Hepatitis-positive * having participated in another clinical study in the 12 months prior to recruitment * presenting symptoms of endometriosis
💊

What it tests

  • Circulating-mirna
📍

Where

1 site
CUSL
Brussels, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy